Nathalie LeVasseur

17PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Korean languagePredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with Triple Negative Breast Cancer in Both the Early and Metastatic Setting 2025.

|Apr 27, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update).

|Apr 14, 2026
The Evolution of Targeted Therapies in Early Hormone Receptor-Positive, HER2-Negative Breast Cancer.

Hyejee Ohm, Caroline Lohrisch, Nathalie LeVasseur

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Early Breast Cancer 2025.

Sandeep Sehdev, Anil Abraham Joy, Jean-François Boileau

|Feb 26, 2026
Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast Cancer 2025.

Katarzyna J Jerzak, Aalok Kumar, Jean-François Boileau

|Aug 27, 2025
Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.

Katarzyna J Jerzak, Sandeep Sehdev, Jean-François Boileau

Pageof 3

Frequent Collaborators

7 joint publications

Karen A Gelmon

5 joint publications

Mita Manna

5 joint publications

Christine Simmons

5 joint publications

Christine Brezden-Masley